Michael Bigger is an investor and a trader who has been involved with trading technologies for more than twenty years. He runs the Bigger Capital Fund, LP and he manages money for many institutional investors.
Momentum trader obsessed with risk management and always playing good defense. Former hedge fund manager, prop trader, 15+ years of market experience. Have MBA in Finance from NYU but do NOT believe that markets are efficient.
Penn State Econ major~Scholar of Behavioral Finance & 30yr mkt trader~Proponent of the notion that psychology & emotion recurrently contest the efficient market hypothesis*DISCLAIMER:NEVER trade any security based on my opinions~Live Life~Smile Often
Welcome to StockTwits, home of the human ticker, real time pulse of markets, and sentiment machine. Use StockTwits to follow your favorite stock, investor or trader and dive deep into open analysis and debate.
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.